Arash Ghadar Appointed as Nemaura Medical COO

Nemaura Medical Inc. has welcomed a new member to its executive management team.

The company has hired Arash Ghadar, Ph.D., as chief operating officer. Ghadar most recently spent a decade as technical director of Datalink Electronics (Datalink) in Loughborough, England, where he managed the design team as an autonomous entity within Datalink. He managed daily operations, business planning, legal affairs, finance, sales, and business development of the design team. In this role, he also supervised numerous technical projects for healthcare and industrial customers that included product development lifecycle, feasibility studies, design, development, prototyping, validation, certification, quality management, and volume manufacturing.
 
“Ash will play an important role at Nemaura as we begin to scale up our manufacturing and distribution operations. He brings over 20 years of product development, management and leadership experience spanning both business and technical disciplines. His main area of expertise is in the medical devices sector, and primarily within a contract design and manufacturing setting, that will be a true asset for the company during the commercialization phase of our growth,” CEO Dr. Faz Chowdhury said.
 
Ghadar is currently a non-executive director at Medilink Midlands, the Midlands (England) Life Sciences industry association with a vision to stimulate the growth of the Midlands life science sector.

Ghadar earned a bachelor of science and master’s degrees in electronics and control systems engineering, obtaining a First Class degree and Distinction, respectively. He also earned a Ph.D. in biosensors from the University of Warwick (U.K.).
 
“I am delighted to join Nemaura, a company with a world-class ambition to transform people’s lives. I very much look forward to working with management and the wider team to successfully commercialize the transformational line of non-invasive products the company is developing, beginning with our continuous glucose monitoring devices and sensors for patients with diabetes,” said Ghadar.
 
Nemaura Medical Inc. is developing and commercializing non-invasive wearable diagnostic devices. The company is currently commercializing sugarBEAT and proBEAT. sugarBEAT, a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which may help people with diabetes and pre-diabetes to better manage, reverse, and prevent the onset of diabetes. Nemaura has submitted a PMA (Premarket Approval Application) for sugarBEAT to the U.S. Food and Drug Administration. proBEAT combines non-invasive glucose data processed using artificial intelligence and a digital healthcare subscription service and has been launched in the United States as a general wellness product as part of its BEAT diabetes program.